Latest Technology News

InteliCare Holdings reported a net operating cash outflow of AUD 447,000 for Q1 2025 but remains confident in sustaining operations through active cash management and potential capital raises.

Magnis Energy Technologies advances financing for its Nachu Graphite Project while navigating the complexities of Imperium3 New York Inc’s bankruptcy and ongoing ASX suspension.

Eclipse Metals Ltd reported significant progress in its March 2025 quarter, highlighting new high-grade rare earth mineralisation in Greenland and a strategic uranium project earn-in agreement in Australia.

4DS Memory Limited has successfully manufactured its first 20nm memory cell array, marking a pivotal step in its ReRAM technology development, while raising $8.6 million through a placement and Share Purchase Plan to fuel ongoing innovation.

1414 Degrees Ltd advances its transformation into a full-service decarbonised energy provider, delivering key technology and commercial milestones in Q3 FY25 while maintaining a stable cash position.

Vectus Biosystems advances its lead fibrosis drug VB0004 with validated Phase I safety data and strategic cost reductions, while actively pursuing licensing partnerships in China.

BPH Global Ltd has raised $609,000 through a targeted placement and made significant strides in its Indonesian seaweed venture, including binding offtake agreements and R&D breakthroughs on mineral extraction.

Kinetiko Energy reports encouraging progress in South African gas exploration, with improved well performance and a drilling optimisation study revealing key production enhancements.

Australian Rare Earths Limited (ASX: AR3) has secured a $5 million government grant to advance its Koppamurra Rare Earths Project, confirmed promising uranium mineralisation at its Overland Project, and raised $3.6 million through a rights issue to accelerate development.

Thrive Tribe Technologies has initiated a corporate restructure focused on revenue growth, appointed a seasoned COO, and rebranded its platform while securing venture debt funding to support expansion.

Dimerix Limited advances its Phase 3 kidney disease trial with FDA acceptance of proteinuria as a primary endpoint and clinches a lucrative licensing agreement in Japan worth up to AU$107 million plus royalties.

Evion Group has marked a key milestone with its first expandable graphite shipment from its India joint venture, while progressing critical permitting for its flagship Maniry Graphite Project in Madagascar. The company also secured $2 million in funding to support expansion and development.